Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) traded up 1.3% during trading on Monday . The company traded as high as $1.07 and last traded at $0.78. Approximately 3,314 shares changed hands during trading, an increase of 47% from the average session volume of 2,257 shares. The stock had previously closed at $0.77.
Nutriband Price Performance
The company’s 50-day simple moving average is $1.17 and its two-hundred day simple moving average is $1.35.
Institutional Investors Weigh In On Nutriband
An institutional investor recently bought a new stake in Nutriband stock. Empery Asset Management LP purchased a new stake in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband makes up about 0.1% of Empery Asset Management LP’s investment portfolio, making the stock its 20th biggest position.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Read More
- Five stocks we like better than Nutriband
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
